● Recruiting

Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus

Condition: Systemic Lupus Erythematosus · Physiopathology · Sponsor: University Hospital, Tours

PhaseN/A

Planned participants50

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersYes

About this study

This study evaluates the variation of expression of the neonatal Fc receptor (FcRn) in Natural Killer T Cells Expressing an Invariant T Receptor (iNKT) and monocytes along with the surface expression of Fc gamma type II receptor (RII) and RIII in active or newly diagnosed lupus patients compared to inactive lupus patients.

This description comes directly from the study's public registry record.

Talk to the study team

Yanis RAMDANI · 0234378919 · yanis.ramdani@univ-tours.fr

Valérie GOUILLEUX-GRUART · valerie.gouilleux@univ-tours.fr

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital

Tours, France

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05859191